Market Place
Sourcing Support
All News #Library
Biotech
mAbxience`s Denosumab Biosimilars Approved by European Commission
02 Jul 2025 //
PR NEWSWIRE
mAbxience, Corapharm Partner for Southeast Europe Deal
02 Jun 2025 //
PRESS RELEASE
mAbxience & Abiogen Pharma Sign Italy Biosimilar Deal
26 May 2025 //
PRESS RELEASE
mAbxience, Egis Ink Deal For Biosimilars In Central Europe
12 Nov 2024 //
PRESS RELEASE
Teva, mAbxience Add New Oncology Biosimilar To Partnership
03 Oct 2024 //
GLOBENEWSWIRE
mAbxience Appoints Jurgen Van Broeck as New CEO
09 May 2024 //
PR NEWSWIRE
Teva enters into oncology biosimilar licensing agreement
16 Apr 2024 //
EUROPEAN PHARMACEUTICAL REVIEW
Teva & mAbxience Announce Licensing Agreement for Oncology Biosimilar Candidate
04 Apr 2024 //
BUSINESSWIRE
Teva inks cancer biosimilar marketing pact with mAbxience
04 Apr 2024 //
FIERCE PHARMA
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.